BioNTech/Pfizer’s mooted EU deal for 70m Covid shots threatens rivals
European health officials have advocated portfolio diversity to help fight different variants
European health officials have advocated portfolio diversity to help fight different variants
More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out
Novavax had a terrible week while Pfizer and Moderna are well off their pandemic highs
Manufacturing woes meant it lost out in race to market with its Covid vaccine
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
Bargain-hunters enter market after sell-off on economic worries
Pyongyang says it has kept its population Covid-free by sealing the country’s borders
Three doses can protect against serious illness and death for a long time, studies suggest
‘I was called an anti-vaxxer, and I took exception to that. My children are vaccinated’
Investors’ appetites for risk increases as fears recede over economic impact of Omicron
Validity will be extended after booster shot without a time limit
Total global output will be more than 20 billion shots for the year
Moderna will be the main vaccine administered over coming weeks to over-60s, over-50s, healthcare workers and younger people in vulnerable groups
‘It was like a tap being turned on from Thursday or Friday last week. It’s been mostly young people’
Johnson unveils ‘temporary and precautionary’ Covid restrictions to slow variant
Tablet has potential to avoid nine of 10 hospitalisations with virus, says pharma giant
Company to submit application for US authorisation by end of the year
Company has filed for regulatory authorisation for shot in India, Indonesia, Philippines
World wrap: Sydney lockdown could last months as daily cases reach record high
US vaccination take-up rates are slowing, as Novavax jab on course for autumn approval
CEO expects early supplies to be used for Covax supplies as analysts eye shot as booster option
Company is talking to governments about creating vaccine manufacturing facilities
Vaccine-makers drop on Wall Street after Biden backs intellectual property waivers
Ireland is in line for up to 2.2m doses of company’s vaccine supply from late-2021
Explainer: The best vaccine is the one that you are offered, say public-health doctors
Oxford scientists test vaccine combinations amid concern over rare side effects
Serum institute is biggest supplier to the international Covax programme
Firm facing complaints over delivery pledges but also reports of possible side effects
EU hoping to buy up to 200m Novavax vaccines
Company to deliver 200m doses to EU with 600,000 to Republic between April and June
EU has deal with company for millions of doses
Daily updates as Ireland embarks on largest inoculation programme in its history
Johnson & Johnson vaccine should be available in Ireland by April
Less than a year on, mRNA inoculations look likely to change the industry forever
Should we be worried about variations between vaccine types?
AstraZeneca raises prospect of delivering doses made in India after talks stall
World round-up: Victoria to enter five-day circuit breaker; NZ likely to begin vaccinating next week
Result from clinical trial comes nearly week after 1m doses of vaccine arrived in country
World round-up: Cases and hospitalisations appear to be on downward trend in US
‘If the people of Europe decide their leaders have yet again failed them, the political backlash could be severe’
European Medicines Agency rules that evidence supports approval for all over age 18
Results from US stronger than those from sites in Latin America and South Africa
Results from a separate, mid-stage trial in South Africa show reduced effectiveness
Cautious strategy combined with risks of fast-spreading strains presents dilemma
Despite efforts to procure vaccine, some nations will only vaccinate 20% of population
AstraZeneca seeks green light while Chinese vaccine disappoints in trial
People who have recovered from infection have already generated a protective immune response to the virus
High-income countries secure billions of doses, with uncertainty for low-income countries
World round-up: India’s daily rise in cases stays below 40,000 for fourth day
Huge logistical task looms when drugs ready since double doses needed for most people
Very little known about terms of contracts the EU has signed with pharma groups
Companies plan to supply 200 million doses of Covid-19 candidate vaccine
Crosswords & puzzles to keep you challenged and entertained
Inquests into the nightclub fire that led to the deaths of 48 people
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices